This page includes the latest FDA filings for Esperion Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | ESPR | DUNS 029516312 |
Device Company | Device | Date |
|---|---|---|
| Esperion Therapeutics, Inc. | Prescription Medication | 2024-10-19 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2024-10-19 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2024-06-08 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2024-04-03 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2024-04-03 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-12-16 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-12-16 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-28 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-28 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-13 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-08 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-06-28 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2023-06-28 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2022-10-12 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2022-10-09 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2021-10-02 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2021-10-02 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2020-11-13 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2020-11-06 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2020-03-14 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2020-03-11 |
| Esperion Therapeutics, Inc. | Nexlizet | 2020-03-09 |
| Esperion Therapeutics, Inc. | Nexletol | 2020-03-06 |
| Esperion Therapeutics, Inc. | Prescription Medication | 2020-03-06 |
| NCAGE Code | 62GZ9 | ESPERION THERAPEUTICS INC |
| CAGE Code | 62GZ9 | ESPERION THERAPEUTICS, INC. ESPERION |
| SEC | 0001434868 | Esperion Therapeutics, Inc. of DELAWARE |